Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 429 of 5804
-
New cocktail aims to tame dangerous leukemia in High-Risk patients
Disease control OngoingThis study aims to evaluate the safety and effectiveness of combining venetoclax with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) in patients with newly diagnosed acute promyelocytic leukemia (APL) who have very high white blood cell counts. APL is a rare type of bl…
Phase: NA • Sponsor: Anhui Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug shows promise in shrinking lung tumors before surgery
Disease control Recruiting nowThis is an exploratory clinical study focusing on the neoadjuvant treatment of non-small cell lung cancer (NSCLC). The study primarily aims to compare the efficacy and safety of Ivonescimab, a novel PD-1/VEGF bispecific antibody, with those of conventional PD-1 inhibitors. Beyond…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Stool test may detect stomach cancer risk before symptoms appear
Diagnosis Recruiting nowThis is a prospective study designed to compare the performance of fecal H. pylori gastric cancer susceptibility analysis and the gastric cancer risk questionnaire for the early detection of gastric cancer. The primary objective is to assess whether each method, individually or i…
Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
New drug cocktail aims to save lungs in scleroderma patients
Disease control Recruiting nowThe study includes adult patients with systemic sclerosis (SSc) with interstitial lung disease (ILD) to evaluate the efficacy and safety of nintedanib plus tocilizumab combination therapy compared to standard therapy (methotrexate, mycophenolate mofetil) for 56 weeks.
Phase: PHASE3 • Sponsor: National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Supercharged immune cells take on cancer in new trial
Disease control Recruiting nowThe primary objectives are to evaluate the safety and efficacy of infusion of autologous tumor associated antigen-specific engineered immune effector cells (EIE).
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Personalized cell therapy takes on GI cancers
Disease control Recruiting nowThe primary objectives are to evaluate the safety and efficacy of infusion of autologous gastro-intestinal (GI) cancer antigen-specific engineered immune effector cells (EIE).
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
AI-Assisted surgery aims to improve brain bleed recovery
Disease control Recruiting nowThe effectiveness of traditional craniotomy in the treatment of intracerebral hemorrhage remains controversial. Minimally invasive surgery, specially, image-guided hematoma aspiration, proves to be effective and may have some advantages compared with craniotomy. This multicenter …
Phase: NA • Sponsor: Xiaolei Chen • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Immune cells engineered to fight lymphoma enter human testing
Disease control Recruiting nowThis is an open label clinical study: Phase Ia is a dose escalation phase, evaluating the safety, tolerability, RP2D, PK characteristics, and preliminary efficacy of IBR900 cell injection in the treatment of relapsed/refractory B-cell non Hodgkin lymphoma (NHL); Phase Ib is the d…
Phase: PHASE1 • Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
AI model aims to predict heart risks after hip surgery in seniors
Knowledge-focused OngoingThis is a multicenter ambispective observational cohort study led by Beijing Anzhen Hospital, Capital Medical University, with China-Japan Friendship Hospital serving as the external validation center. Major adverse cardiovascular events (MACE) occurring after surgery are common…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Brain-Wash breakthrough? new trial takes on deadly ventriculitis
Disease control Recruiting nowVentriculitis is a severe infectious disease of the central nervous system with diverse etiologies. Currently, the treatment for ventriculitis is challenging, with poor prognosis. The mortality rate of ventriculitis is generally reported to be higher than 30%, with the highest re…
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
AI-Powered ECG alerts could catch silent heart rhythm problems before they strike
Diagnosis Recruiting nowOur study aimed to use an AF-predict AI-ECG alert system to help physicians identify patients who need to wear a continuous cardiac rhythm monitor for new diagnoses of atrial fibrillation (AF), atrial flutter (AFL), or atrial arrhythmia with high AF risk, including premature atri…
Phase: NA • Sponsor: National Defense Medical Center, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Fast brain zaps show promise for suicidal teens in new trial
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a fast-acting brain stimulation treatment called transcranial magnetic stimulation (TMS) can help people with depression and suicidal thoughts. The treatment is non-invasive (does not involve surgery or medications), is given over 5 …
Phase: NA • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New drug shows promise for Hard-to-Treat breast cancer subtype
Disease control Recruiting nowThis trial studies a type of advanced breast cancer defined as hormone receptor HR-positive/HER2-negative and classified as non-luminal by gene expression profiling (PAM50). Patients will be treated with trastuzumab deruxtecan (T-DXd) or with physician's choice of CDK4/6 inhibito…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Spinal cord injury patients get first shot at novel cell delivery device
Disease control Recruiting nowThe DOSED clinical study evaluates the safety and utility of a novel delivery device to deliver LCTOPC1, a cell therapy, to the spinal cord of patients with a spinal cord injury (SCI). LCTOPC1 is designed to replace or support cells that are absent or dysfunctional due to traumat…
Phase: PHASE1 • Sponsor: Lineage Cell Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for myeloma: experimental drug etentamig enters human trials
Disease control Recruiting nowMultiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can…
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could immune cells fight Alzheimer's? new study tests Long-Term safety
Disease control Recruiting nowOpen-Label Extension Protocol to SNK01-AD01 Study
Phase: PHASE2 • Sponsor: NKGen Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Boron therapy takes aim at deadly brain tumors
Disease control Recruiting nowThis Phase I/II study, titled 'A Phase I/II Study to Evaluate Safety and Efficacy of the Boron Neutron Capture Therapy (BNCT) using B10 L-BPA as Boron Carrier in Malignant Brain Tumors.', aims to assess the efficacy of B10 L-BPA with BNCT in patients with malignant brain tumors. …
Phase: PHASE1, PHASE2 • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy aims to control brain tumors in lung cancer patients
Disease control Recruiting nowFor non-small cell lung cancer brain metastases, stereotactic radiotherapy is gradually replacing whole brain radiotherapy as the standard treatment. When patients have multiple brain metastases or larger tumors (diameter\>2cm), single session stereotactic radiotherapy (SRS) may …
Phase: PHASE3 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New weekly shot aims to tame Sjögren's Flare-Ups
Disease control Recruiting nowThis is a Phase 2b, multicenter, randomized, double-blinded, placebo-controlled study to assess the efficacy and safety of IMVT-1402 in adult participants with moderate to severe systemic primary Sjogren's disease (SjD).
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New family program aims to prevent multiple health crises in latino immigrant communities
Prevention Recruiting nowThis study aims to prevent syndemic health conditions by decreasing acculturative stress and promoting resilience via SER Familia (Salud, Estrés y Resilencia en Familias/ Health, Stress, and Resilience in Families), a family-based intervention. SER Familia is a six-session interv…
Phase: NA • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC